Heron Therapeutics Inc (HRTX)

Operating Cash Flow Growth

79.64%

Quarterly · Period ending:

HRTX logo

HRTX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported79.64%
HRTX Quarterly Cash from Operations YoY % (-100.00% → 79.64%)
High-resolution chart · PNG

HRTX operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
-49.073%
-2,368.1382%
-269.7059%
-347.2455%
54.6483%
40.766%
-43.75%
71.4286%
-600%
95.4545%
77.7778%
-800%
84.6154%
-833.3333%
325%
112.5%
-8.3333%
108.1081%
84.6154%
70.3704%
57.1429%
-825%
13.3333%
-8%
-7.6923%
20%
-20%
0%
39.5349%
79.1667%
-4.1667%
-308.3333%
-760%
-9.0909%
-60%
192.3077%
-150%
-175%
-150%
-30%
84.6154%
-60%
45.4545%
-100%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.